Taysha Gene Therapies, Inc.
Hedge Funds Holdings
Last updated:
Taysha Gene Therapies, Inc.‘s stocks are currently a part of 28 hedge funds’ portfolios, which represents 20.75% of the total amount of its stocks outstanding. This makes up a total of 9.12M shares of Taysha Gene Therapies, Inc.. Compared to the previous quarter, the number fell by -52.92% or -10.25M shares fewer. As for the holding position changes, 25% (7) of current hedge fund investors increased the number of shares held, 32.14% (9) of current holders sold a part of the shares held, and 25% (7) closed the holdings completely. 4 hedge funds are new holders of Taysha Gene Therapies, Inc. stock in Q1 2023, it is 14.29% of total holders.
Hedge funds holding Taysha Gene Therapies (Q3 2020 – Q1 2023)
| Q3 2020 | 46 |
|---|---|
| Q4 2020 | 50 |
| Q1 2021 | 45 |
| Q2 2021 | 48 |
| Q3 2021 | 47 |
| Q4 2021 | 64 |
| Q1 2022 | 71 |
| Q2 2022 | 57 |
| Q3 2022 | 51 |
| Q4 2022 | 51 |
| Q1 2023 | 28 |
Hedge funds changes in Taysha Gene Therapies positions (Q3 2020 – Q1 2023)
| Q3 2020 | 46 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2020 | 23 | 8 | 9 | 19 | -9 |
| Q1 2021 | 3 | 17 | 14 | 8 | 3 |
| Q2 2021 | 11 | 26 | 5 | 8 | -2 |
| Q3 2021 | 4 | 21 | 11 | 5 | 6 |
| Q4 2021 | 21 | 23 | 8 | 4 | 8 |
| Q1 2022 | 15 | 27 | 15 | 8 | 6 |
| Q2 2022 | 14 | 15 | 23 | 26 | -21 |
| Q3 2022 | 2 | 11 | 21 | 8 | 9 |
| Q4 2022 | 14 | 20 | 9 | 14 | -6 |
| Q1 2023 | 4 | 7 | 9 | 7 | 1 |
Hedge funds changes in Taysha Gene Therapies stock options (Q3 2020 – Q1 2023)
| Q3 2020 | 0 | 0 |
|---|---|---|
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 0 | 0 |
| Q1 2022 | 108,000 | 163,000 |
| Q2 2022 | 89,000 | 0 |
| Q3 2022 | 191,000 | 0 |
| Q4 2022 | 189,142 | 84,524 |
| Q1 2023 | 479,000 | 3,190,000 |